Neuralstem, Inc. (NASDAQ:CUR), a biopharmaceutical company focused on the development of central nervous system therapies based on its neural stem cell technology, announced …
Neuralstem, Inc. (NASDAQ:CUR), a biopharmaceutical company focused on the development of central nervous system therapies based on its neural stem cell technology, announced that …
Neuralstem, Inc. (NASDAQ:CUR), a biopharmaceutical company focused on the development of central nervous system therapies based on its neural stem cell technology, reported its …
Northwest Biotherapeutics, Inc (NASDAQ:NWBO) is up 26% in pre-market trading Tuesday, after the company provided an operations updates on its phase 1 and …
Analysts weigh in on two biotech stocks, Novavax, Inc. (NASDAQ:NVAX) and Neuralstem, Inc.
Neuralstem, Inc. (NASDAQ:CUR), a biopharmaceutical company focused on the development of central nervous system therapies based on its neuronal stem cell technology, announced the …
Healthcare analysts weighed in today on biotech stocks Inovio Pharmaceuticals Inc (NASDAQ:INO) and Neuralstem, Inc. (NASDAQ:CUR), while both stocks were among the top performers from the …
Neuralstem, Inc. (NASDAQ:CUR), a bipharmaceutical company using neural stem cell technology to develop regenerative theroapies and small molecule pharmaceutical drugs for CNS diseases and …
Neuralstem, Inc. (NASDAQ:CUR), a biopharmaceutical company leveraging its unique human neural stem cell-derived platform to identify and develop novel neurogenic therapies for diseases of …
